656 related articles for article (PubMed ID: 14631546)
1. Hyperviscosity syndrome in plasma cell dyscrasias.
Mehta J; Singhal S
Semin Thromb Hemost; 2003 Oct; 29(5):467-71. PubMed ID: 14631546
[TBL] [Abstract][Full Text] [Related]
2. Hyperviscosity in plasma cell dyscrasias.
Kwaan HC
Clin Hemorheol Microcirc; 2013; 55(1):75-83. PubMed ID: 23455837
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hyperviscosity syndrome in the patients with plasma cell dyscrasias.
Kes P; Pecanić Z; Getaldić B; Ratković-Gusić I
Acta Med Croatica; 1996; 50(4-5):173-7. PubMed ID: 9046114
[TBL] [Abstract][Full Text] [Related]
4. Variability of plasma viscosity in monoclonal IgM gammopathies.
Visentin I; Mares M; Bertolo C; Terribile V; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(5):747-58. PubMed ID: 1709909
[TBL] [Abstract][Full Text] [Related]
5. [Alleviation of ocular complications of the hyperviscosity syndrome in Waldenström's macroglobulinemia using plasma exchange].
Malecaze F; Mathis A; Gonzales C; Lloveras JJ; Goudable C; Arlet P; Bec P
J Fr Ophtalmol; 1986; 9(5):367-71. PubMed ID: 3100607
[TBL] [Abstract][Full Text] [Related]
6. [Blood hyperviscosity syndromes].
Crepaldi G; Calabrò A; Belloni M; Ongaro G; Muggeo M
Ric Clin Lab; 1983; 13 Suppl 3():89-104. PubMed ID: 6424223
[TBL] [Abstract][Full Text] [Related]
7. IgA myeloma complicated by fractures of the bones and hyperviscosity syndrome--report of an autopsied case.
Tojo K; Morita A; Miki T; Morii H; Mitsuhashi T; Hashimoto R; Kadoya Y
Osaka City Med J; 1990 May; 36(1):61-70. PubMed ID: 2385441
[TBL] [Abstract][Full Text] [Related]
8. Studies of the hyperviscosity syndrome. II. Macroglobulinemia.
MacKenzie MR; Babcock J
J Lab Clin Med; 1975 Feb; 85(2):227-34. PubMed ID: 803540
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and biohumoral significance of plasma viscosity in patients with paraproteinemia without clinical hyperviscosity syndrome. A study of 40 cases (author's transl)].
Barbarano L; Rossi AF; Vendrami R; Van Westerhout G; Sala G; Canesi BA
Haematologica; 1981 Aug; 66(4):452-60. PubMed ID: 6797880
[No Abstract] [Full Text] [Related]
10. Hyperviscosity syndrome in paraproteinemia. Managed by plasma exchange; monitored by serum tests.
Beck JR; Quinn BM; Meier FA; Rawnsley HM
Transfusion; 1982; 22(1):51-3. PubMed ID: 6801828
[TBL] [Abstract][Full Text] [Related]
11. CD3+ T lymphocytes and interleukin 2 in myelomatous blood hyperviscosity syndrome treated with plasmapheresis.
Usnarska-Zubkiewicz L
Arch Immunol Ther Exp (Warsz); 1998; 46(5):317-22. PubMed ID: 9832072
[TBL] [Abstract][Full Text] [Related]
12. [Hyperviscosity syndrome in plasma cell dyscrasias].
Somer T
Duodecim; 1977; 93(9):586-603. PubMed ID: 406132
[No Abstract] [Full Text] [Related]
13. Plasma exchange in the long-term management of Waldenström's macroglobulinemia.
Buskard NA; Galton DA; Goldman JM; Kohner EM; Grindle CF; Newman DL; Twinn KW; Lowenthal RM
Can Med Assoc J; 1977 Jul; 117(2):135-7. PubMed ID: 406031
[TBL] [Abstract][Full Text] [Related]
14. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
Menke MN; Feke GT; McMeel JW; Treon SP
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744
[TBL] [Abstract][Full Text] [Related]
15. Recognizing hyperviscosity syndrome in patients with Waldenstrom macroglobulinemia.
Mullen EC; Wang M
Clin J Oncol Nurs; 2007 Feb; 11(1):87-95. PubMed ID: 17441400
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
[TBL] [Abstract][Full Text] [Related]
17. Hyperviscosity syndrome: efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenström's type.
Höffkes HG; Heemann UW; Teschendorf C; Uppenkamp M; Philipp T
Clin Nephrol; 1995 May; 43(5):335-8. PubMed ID: 7634550
[TBL] [Abstract][Full Text] [Related]
18. [Hyperviscosity syndrome].
Dumas G; Merceron S; Zafrani L; Canet E; Lemiale V; Kouatchet A; Azoulay E
Rev Med Interne; 2015 Sep; 36(9):588-95. PubMed ID: 25778852
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmologic techniques to assess the severity of hyperviscosity syndrome and the effect of plasmapheresis in patients with Waldenström's macroglobulinemia.
Menke MN; Feke GT; McMeel JW; Treon SP
Clin Lymphoma Myeloma; 2009 Mar; 9(1):100-3. PubMed ID: 19362987
[TBL] [Abstract][Full Text] [Related]
20. Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenström and multiple myeloma: influence on blood rheology and the microcirculation.
Reinhart WH; Lutolf O; Nydegger UR; Mahler F; Straub PW
J Lab Clin Med; 1992 Jan; 119(1):69-76. PubMed ID: 1727909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
